All Posts: triple-negative breast cancer

• ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times

  The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.

  Category: GUMC Stories Tags: breast cancer, cancer, clinical trials, Georgetown Lombardi, research, triple-negative breast cancer

• Clinical Trial Result Leads to New Treatment Option for Hard-to-Treat Breast Cancer

  Category: GUMC Stories Tags: breast cancer, cancer, Georgetown Lombardi, triple-negative breast cancer